pyrazinamide has been researched along with Hyperuricemia in 15 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
Hyperuricemia: Excessive URIC ACID or urate in blood as defined by its solubility in plasma at 37 degrees C; greater than 0.42mmol per liter (7.0mg/dL) in men or 0.36mmol per liter (6.0mg/dL) in women. This condition is caused by overproduction of uric acid or impaired renal clearance. Hyperuricemia can be acquired, drug-induced or genetically determined (LESCH-NYHAN SYNDROME). It is associated with HYPERTENSION and GOUT.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hyperuricemia is frequently reported in adults, but there are few data for the pediatric population." | 5.42 | Is Hyperuricemia Overlooked when Treating Pediatric Tuberculosis Patients with Pyrazinamide? ( Aslan, AT; Budakoğlu, I; Şişmanlar, T, 2015) |
| "Pyrazinamide is an antituberculous drug that is administered as a two-month course during treatment of pulmonary tuberculosis." | 5.35 | Epidemiological survey of hyperuricemia as an adverse reaction to antituberculous therapy with pyrazinamide. ( Murakami, T; Nikai, T; Ogawa, K; Taki, H, 2008) |
| "Hyperuricemia is frequently reported in adults, but there are few data for the pediatric population." | 1.42 | Is Hyperuricemia Overlooked when Treating Pediatric Tuberculosis Patients with Pyrazinamide? ( Aslan, AT; Budakoğlu, I; Şişmanlar, T, 2015) |
| "Pyrazinamide is an antituberculous drug that is administered as a two-month course during treatment of pulmonary tuberculosis." | 1.35 | Epidemiological survey of hyperuricemia as an adverse reaction to antituberculous therapy with pyrazinamide. ( Murakami, T; Nikai, T; Ogawa, K; Taki, H, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (53.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gerdan, V | 1 |
| Akkoc, N | 1 |
| Ucan, ES | 1 |
| Bulac Kir, S | 1 |
| Şişmanlar, T | 1 |
| Aslan, AT | 1 |
| Budakoğlu, I | 1 |
| Taki, H | 1 |
| Ogawa, K | 1 |
| Murakami, T | 1 |
| Nikai, T | 1 |
| Murugaiyah, V | 1 |
| Chan, KL | 1 |
| Yamamoto, T | 1 |
| CULLEN, JH | 2 |
| EARLY, LJ | 1 |
| FIORE, JM | 2 |
| LEVINE, M | 1 |
| SHAPIRO, M | 1 |
| HYDE, L | 1 |
| WEISS, W | 1 |
| KAPLAN, A | 1 |
| EISENBERG, GM | 1 |
| FLIPPIN, HF | 1 |
| SCOTT, JT | 1 |
| DIXON, AS | 1 |
| BYWATERS, EG | 1 |
| PETTY, TL | 1 |
| DALRYMPLE, GV | 1 |
| KERSHBAUM, A | 1 |
| FEINBERG, LJ | 1 |
| DE LEON, AC | 1 |
| BELLET, S | 1 |
| SCHNEEWEISS, J | 1 |
| POOLE, GW | 1 |
| Solangi, GA | 1 |
| Zuberi, BF | 1 |
| Shaikh, S | 1 |
| Shaikh, WM | 1 |
| Gupta, S | 1 |
| Gupta, V | 1 |
| Kapoor, B | 1 |
| Kapoor, V | 1 |
1 review available for pyrazinamide and Hyperuricemia
| Article | Year |
|---|---|
[Effect of ethanol on uric acid level].
Topics: Acetaldehyde; Animals; Erythrocytes; Ethanol; Gout; Humans; Hyperuricemia; Purines; Pyrazinamide; Ur | 2003 |
14 other studies available for pyrazinamide and Hyperuricemia
| Article | Year |
|---|---|
Paradoxical increase in uric acid level with allopurinol use in pyrazinamide-induced hyperuricaemia.
Topics: Adult; Allopurinol; Arthritis, Psoriatic; Humans; Hyperuricemia; Male; Pyrazinamide; Treatment Outco | 2013 |
Is Hyperuricemia Overlooked when Treating Pediatric Tuberculosis Patients with Pyrazinamide?
Topics: Adolescent; Allopurinol; Antitubercular Agents; Child; Child, Preschool; Drug Administration Schedul | 2015 |
Epidemiological survey of hyperuricemia as an adverse reaction to antituberculous therapy with pyrazinamide.
Topics: Antitubercular Agents; Data Collection; Female; Humans; Hyperuricemia; Male; Middle Aged; Pyrazinami | 2008 |
Mechanisms of antihyperuricemic effect of Phyllanthus niruri and its lignan constituents.
Topics: Animals; Disease Models, Animal; Drug Synergism; Gout Suppressants; Hyperuricemia; Inhibitory Concen | 2009 |
The occurrence of hyperuricemia during pyrazinamide-isoniazid therapy.
Topics: Blood; Humans; Hyperuricemia; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Pyrazinamide; Pyrimidin | 1956 |
Studies of hyperuricemia produced by pyrazinamide.
Topics: Humans; Hyperuricemia; Niacin; Nicotinic Acids; Pyrazinamide; Uric Acid | 1957 |
Hyperuricemia due to pyrazinamide.
Topics: Humans; Hyperuricemia; Niacin; Nicotinic Acids; Pyrazinamide; Uric Acid | 1957 |
The effect of probenecid on pyrazinamide blood levels and pyrazinamide-induced hyperuricemia.
Topics: Humans; Hyperuricemia; Niacin; Nicotinic Acids; Probenecid; Pyrazinamide; Uric Acid | 1957 |
ASSOCIATION OF HYPERURICAEMIA AND GOUT WITH HYPERPARATHYROIDISM.
Topics: Adenoma; Blood Chemical Analysis; Diagnosis; Gout; Humans; Hyperparathyroidism; Hyperuricemia; Nephr | 1964 |
INHIBITION OF PYRAZINAMIDE HYPERURICEMIA BY SMALL DOSES OF ACETYLSALICYLIC ACID.
Topics: Aspirin; Blood Chemical Analysis; Drug Therapy; Humans; Hyperuricemia; Pyrazinamide; Toxicology; Tub | 1964 |
The effect of pyrazinamide-induced hyperuricemia on serum lipids.
Topics: Humans; Hyperuricemia; Lipids; Pyrazinamide; Uric Acid | 1960 |
Hyperuricaemia due to pyrazinamide.
Topics: Humans; Hyperuricemia; Pyrazinamide; Uric Acid | 1960 |
Pyrazinamide induced hyperuricemia in patients taking anti-tuberculous therapy.
Topics: Adult; Antitubercular Agents; Creatinine; Female; Humans; Hyperuricemia; Male; Prospective Studies; | 2004 |
Pyrazinamide induced hyperuricaemia presenting as severe bilateral leg cramps.
Topics: Adult; Antitubercular Agents; Humans; Hyperuricemia; Male; Muscle Cramp; Pyrazinamide | 2007 |